Esma Altunoğlu

445 total citations
29 papers, 338 citations indexed

About

Esma Altunoğlu is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Molecular Biology. According to data from OpenAlex, Esma Altunoğlu has authored 29 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Physiology and 5 papers in Molecular Biology. Recurrent topics in Esma Altunoğlu's work include Dialysis and Renal Disease Management (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Adipose Tissue and Metabolism (3 papers). Esma Altunoğlu is often cited by papers focused on Dialysis and Renal Disease Management (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Adipose Tissue and Metabolism (3 papers). Esma Altunoğlu collaborates with scholars based in Türkiye, United States and Cambodia. Esma Altunoğlu's co-authors include Füsun Erdenen, Hafize Uzun, Remise Gelışgen, Volkan Sözer, Hakan Yavuzer, Pınar Atukeren, Ömür Tabak, Sema Yarman, Refik Tanakol and Ender Ülgen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomedicine & Pharmacotherapy and Biomolecules.

In The Last Decade

Esma Altunoğlu

27 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esma Altunoğlu Türkiye 12 97 88 51 47 46 29 338
Xianghua Zhuang China 12 174 1.8× 84 1.0× 80 1.6× 27 0.6× 56 1.2× 32 419
Kiran Chandrashekar United States 10 136 1.4× 77 0.9× 52 1.0× 21 0.4× 76 1.7× 19 439
Nicolas Godin Canada 7 185 1.9× 48 0.5× 74 1.5× 34 0.7× 37 0.8× 8 437
Anni Song China 9 142 1.5× 46 0.5× 40 0.8× 34 0.7× 58 1.3× 16 424
Yousheng Li China 10 116 1.2× 57 0.6× 28 0.5× 34 0.7× 27 0.6× 19 350
Ruili Yin China 11 102 1.1× 56 0.6× 89 1.7× 43 0.9× 57 1.2× 22 324
Lizhen Liao China 14 153 1.6× 81 0.9× 42 0.8× 25 0.5× 69 1.5× 29 483
Shoujin Hao United States 12 198 2.0× 59 0.7× 73 1.4× 37 0.8× 20 0.4× 29 442
Anu Shah United States 8 268 2.8× 83 0.9× 75 1.5× 31 0.7× 63 1.4× 12 486
Suzan Tabur Türkiye 12 96 1.0× 53 0.6× 140 2.7× 29 0.6× 38 0.8× 36 424

Countries citing papers authored by Esma Altunoğlu

Since Specialization
Citations

This map shows the geographic impact of Esma Altunoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esma Altunoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esma Altunoğlu more than expected).

Fields of papers citing papers by Esma Altunoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esma Altunoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esma Altunoğlu. The network helps show where Esma Altunoğlu may publish in the future.

Co-authorship network of co-authors of Esma Altunoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Esma Altunoğlu. A scholar is included among the top collaborators of Esma Altunoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esma Altunoğlu. Esma Altunoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sayılı, Uğurcan, et al.. (2020). Evaluation of serum zonulin level in prediabetic patients. Annales d Endocrinologie. 82(1). 1–7. 2 indexed citations
3.
Sözer, Volkan, Füsun Erdenen, Esma Altunoğlu, et al.. (2019). Clinical Value of Circulating Microribonucleic Acids miR-1 and miR-21 in Evaluating the Diagnosis of Acute Heart Failure in Asymptomatic Type 2 Diabetic Patients. Biomolecules. 9(5). 193–193. 31 indexed citations
4.
Erdenen, Füsun, et al.. (2019). The Relationship between Plasma Taurine Levels and Diabetic Complications in Patients with Type 2 Diabetes Mellitus. Biomolecules. 9(3). 96–96. 39 indexed citations
5.
Erdenen, Füsun, et al.. (2018). Association of Plasma Pentraxin-3 Levels with Retinopathy and Systemic Factors in Diabetic Patients. Metabolic Syndrome and Related Disorders. 16(7). 358–365. 4 indexed citations
6.
Altunoğlu, Esma, et al.. (2018). Results of Diabetes Risk Screening in November 14 World Diabetes Day at a Training and Research Hospital. Journal of Academic Research in Nursing.
7.
Atukeren, Pınar, Mahir Cengız, Hakan Yavuzer, et al.. (2017). The efficacy of donepezil administration on acetylcholinesterase activity and altered redox homeostasis in Alzheimer’s disease. Biomedicine & Pharmacotherapy. 90. 786–795. 41 indexed citations
8.
Erdenen, Füsun, et al.. (2016). Serum Osteoprotegerin Levels Related With Cardiovascular Risk Factors in Chronic Kidney Disease. Journal of Clinical Laboratory Analysis. 30(6). 811–817. 13 indexed citations
9.
Tabak, Ömür, Volkan Sözer, Füsun Erdenen, et al.. (2016). WITHDRAWN: Relationship between circulating irisin, retinol binding protein-4, adiponectin and inflammatory mediators in patients with metabolic syndrome. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 1 indexed citations
10.
Özcan, Oğuzhan, et al.. (2014). Is Automated Kinetic Measurement Superior to End-point for Advanced Oxidation Protein Product?. Clinical Laboratory. 60(06/2014). 925–30. 1 indexed citations
11.
Altunoğlu, Esma, Gülcan Güntaş, Füsun Erdenen, et al.. (2014). Ischemia‐modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease. Geriatrics and gerontology international. 15(7). 872–880. 36 indexed citations
12.
Uzun, Hafize, Füsun Erdenen, Esma Altunoğlu, et al.. (2014). Soluble Lectin‐Like Oxidized LDL Receptor 1 as a Possible Mediator of Endothelial Dysfunction in Patients With Metabolic Syndrome. Journal of Clinical Laboratory Analysis. 29(3). 184–190. 18 indexed citations
13.
Altunoğlu, Esma, Füsun Erdenen, Remise Gelışgen, et al.. (2014). Serum Adenosine Deaminase Activity and Neopterin Levels during Therapy in Patients with Pulmonary Tuberculosis and Community-Acquired Pneumonia. 15(2). 78–82. 1 indexed citations
15.
Altunoğlu, Esma, et al.. (2013). The Impact of Obesity and Insulin Resistance on Iron and Red Blood Cell Parameters: A Single Center, Cross-Sectional Study. SHILAP Revista de lepidopterología. 31(1). 61–67. 16 indexed citations
16.
Erdenen, Füsun, Esma Altunoğlu, Hayriye Erman, et al.. (2013). Evaluation of Serum Paraoxonase and Arylesterase Activities in Subjects with Asthma and Chronic Obstructive Lung Disease. Clinical Laboratory. 59(11+12/2013). 1331–7. 15 indexed citations
17.
Yarman, Sema, et al.. (2011). Interleukin-6-producing pheochromocytoma presenting with fever of unknown origin. Clinics. 66(10). 1843–1845. 22 indexed citations
18.
Erdenen, Füsun, et al.. (2011). THYROID DISEASE, TSH SCREENING, AND COMORBIDITY. 1 indexed citations
19.
Altunoğlu, Esma, et al.. (2011). Obesity and Thyroid Function. 12(2). 69–71. 2 indexed citations
20.
Erdenen, Füsun, Ahmet Burak Toros, Hasan Bektaş, et al.. (2009). Diagnostic and prognostic value of tumor M2-pyruvate kinase levels in patients with colorectal cancer. The Turkish Journal of Gastroenterology. 24(1). 36–42. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026